RANI(Rani Therapeutics Holdings, Inc.) 的内部人交易:医疗保健,生物技术。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 交易日 | 姓名 | 职务 | 类型 | 股数 | 价格 |
|---|---|---|---|---|---|
| 2026-07-21 | IMRAN MIR A | 董事、10% 股东 | 公开市场买入 | 36,000 | $0.69 |
| 2026-07-17 | Imran Talat | Chief Executive Officer | 公开市场买入 | 35,000 | $0.72 |
| 2026-03-27 | Javadi Alireza | Chief Technical Officer | 公开市场卖出 | 386 | $0.78 |
| 2025-10-23 | IMRAN MIR A | 董事、10% 股东 | 公开市场买入 | 2,083,334 | — |
| 2025-10-23 | IMRAN MIR A | 董事、10% 股东 | 公开市场买入 | 2,083,334 | $0.60 |
| 2025-10-21 | South Cone Investments Limited Partnership | 10% 股东 | 公开市场卖出 | 4,000,000 | $2.77 |
| 2025-10-20 | South Cone Investments Limited Partnership | 10% 股东 | 公开市场卖出 | 1,923,000 | $2.41 |
| 2024-12-27 | Imran Talat | Chief Executive Officer | 公开市场卖出 | 8,014 | $1.41 |
| 2024-12-13 | McKinley Kate | Chief Business Officer | 公开市场买入 | 17,960 | $1.67 |
| 2024-12-09 | Imran Talat | Chief Executive Officer | 公开市场买入 | 10,296 | $1.94 |